Literature DB >> 25525145

Cluster of cases of massive hemorrhage associated with anticoagulant detection in race horses.

Francisco R Carvallo1, Robert Poppenga1, Hailu Kinde1, Santiago S Diab1, Akinyi C Nyaoke1, Ashley E Hill1, Rick M Arthur1, Francisco A Uzal2.   

Abstract

Five horses originating from 4 different California race tracks were submitted to the California Animal Health and Food Safety Laboratory for necropsy and diagnostic workup. The 5 horses had a history of sudden collapse and death during exercise. In all of them, massive hemoperitoneum and hemorrhages in other cavities or organs were observed. The liver from these 5 animals and from 27 horses that had been euthanized due to catastrophic leg injuries (controls) were subjected to a rodenticide anticoagulant screen. Traces of brodifacoum, diphacinone, or bromadiolone were detected in the 5 horses with massive bleeding (5/5), and no traces of rodenticides were detected in control horses (0/27). Other frequent causes of massive hemorrhages in horses were ruled out in 4 of the cases; one of the horses had a pelvic fracture. Although only traces of anticoagulants were found in the livers of these horses and the role of these substances in the massive bleeding remains uncertain, it is speculated that exercise-related increases in blood pressure may have reduced the threshold for toxicity of these anticoagulants.
© 2014 The Author(s).

Entities:  

Keywords:  Brodifacoum; bromadiolone; diphacinone; horses; rodenticides; warfarin

Mesh:

Substances:

Year:  2015        PMID: 25525145     DOI: 10.1177/1040638714559970

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  1 in total

1.  Determining an approximate minimum toxic dosage of diphacinone in horses and corresponding serum, blood, and liver diphacinone concentrations: a pilot study.

Authors:  Megan C Romano; Kyle A Francis; Jennifer G Janes; Robert H Poppenga; Michael S Filigenzi; Darko Stefanovski; Cynthia L Gaskill
Journal:  J Vet Diagn Invest       Date:  2022-04-02       Impact factor: 1.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.